Characteristics associated with response to teduglutide in pediatric short bowel syndrome-associated intestinal failure: Post hoc analysis of open-label long-term extension trials
Intestinal Failure · 2026-10 · 12 · 100398
DOI: 10.1016/j.intf.2026.100398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intestinal Failure, 2026-10. Verfasst von Susan Hill und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Gastroenterology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shire Human Genetic Therapies, Takeda Pharmaceuticals USA Inc, Takeda Pharmaceuticals U.S.A..
Abstract (Originalsprache)
Background
Teduglutide can reduce dependence on parenteral nutrition and/or intravenous fluids (PN/IV) in children with short bowel syndrome-associated intestinal failure (SBS-IF). Material and methods: A post-hoc analysis was conducted using data from open-label long-term extension (LTE) trials (NCT02949362, NCT02954458) through 96 weeks. Patients were grouped by whether or not they attained: consistent response (≥ 20% PN/IV volume reduction from baseline for ≥ 90 consecutive days during both the parent and LTE studies); and sustained enteral autonomy (100% PN/IV volume reduction from baseline for ≥ 90 consecutive days at any point during 96 weeks of treatment). Univariate analysis identified factors associated with response to teduglutide.
Results
Overall, 23/69 patients had consistent response and 18/69 patients had sustained enteral autonomy. Significant differences were observed between those who did and did not attain consistent response in characteristics including age, presence of ileocecal valve, time since SBS diagnosis, and baseline PN/IV volume; and between patients with and without sustained enteral autonomy in age, length of remaining small intestine, and baseline PN/IV volume and duration. Older age at baseline and greater time since SBS diagnosis were associated with increased likelihood of consistent response (p < 0.05). Older age at baseline and greater length of remaining small intestine were associated with increased likelihood of sustained enteral autonomy (p < 0.05).
Conclusions
Of 69 children with SBS-IF, 33.3% had consistent response to teduglutide and 26.1% had sustained enteral autonomy. Age at baseline, time since diagnosis, and length of remaining small intestine were associated with response or enteral autonomy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatric Gastroenterology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
- Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
- Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- Takeda Pharmaceuticals USA., Inc., Lexington, MA, USA.
- Division of Gastroenterology, Hepatology, and Nutrition, UCLA Mattel Children's Hospital, Los Angeles, CA, USA.
Förderung
- Shire Human Genetic Therapies
- Takeda Pharmaceuticals USA Inc
- Takeda Pharmaceuticals U.S.A.
Zitieren
APA
Hill, S., Carter, B., Cohran, V., Kocoshis, S., Nazarey, P., Robinson, I., Terreri, B., Venick, R., Wales, P. W., & Wendel, D. (2026). Characteristics associated with response to teduglutide in pediatric short bowel syndrome-associated intestinal failure: Post hoc analysis of open-label long-term extension trials. Intestinal Failure, 12, 100398. https://doi.org/10.1016/j.intf.2026.100398
Vancouver
Hill S, Carter B, Cohran V, Kocoshis S, Nazarey P, Robinson I, et al. Characteristics associated with response to teduglutide in pediatric short bowel syndrome-associated intestinal failure: Post hoc analysis of open-label long-term extension trials. Intestinal Failure. 2026;12:100398. doi:10.1016/j.intf.2026.100398
BibTeX
@article{Hill2026,
author = {Hill, Susan and Carter, Beth and Cohran, Valeria and Kocoshis, Samuel and Nazarey, Pradeep and Robinson, Ian and Terreri, Brian and Venick, Robert and Wales, Paul W and Wendel, Danielle},
title = {Characteristics associated with response to teduglutide in pediatric short bowel syndrome-associated intestinal failure: Post hoc analysis of open-label long-term extension trials},
journal = {Intestinal Failure},
year = {2026},
volume = {12},
pages = {100398},
doi = {10.1016/j.intf.2026.100398}
}
EUVIMED